Patents by Inventor Gunter Meister

Gunter Meister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High complexity siRNA pools
    Patent number: 10407677
    Abstract: The present invention relates to a method for producing pools of siRNA molecules suitable for RNA interference.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: September 10, 2019
    Assignees: INTANA BIOSCIENCE GmbH, siTools Biotech GmbH
    Inventors: Gunter Meister, Michael Hannus
  • HIGH COMPLEXITY siRNA POOLS
    Publication number: 20150132848
    Abstract: The present invention relates to a method for producing pools of siRNA molecules suitable for RNA interference.
    Type: Application
    Filed: April 25, 2013
    Publication date: May 14, 2015
    Inventors: Gunter Meister, Michael Hannus
  • Anti-microRNA oligonucleotide molecules
    Patent number: 8937173
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: January 20, 2015
    Assignee: The Rockefeller University
    Inventors: Thomas H. Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • Anti-MicroRNA Oligonucleotide Molecules
    Publication number: 20140335605
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Application
    Filed: July 29, 2014
    Publication date: November 13, 2014
    Inventors: Thomas H. Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • Anti-microRNA oligonucleotide molecules
    Patent number: 8816060
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Grant
    Filed: November 13, 2012
    Date of Patent: August 26, 2014
    Assignee: Rockefeller University
    Inventors: Thomas H. Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • Anti-MicroRNA oligonucleotide molecules
    Patent number: 8318926
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: November 27, 2012
    Assignee: Rockefeller University
    Inventors: Thomas H. Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • Anti-MicroRNA Oligonucleotide Molecules
    Publication number: 20120115220
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Application
    Filed: January 9, 2012
    Publication date: May 10, 2012
    Applicant: ROCKEFELLER UNIVERSITY
    Inventors: Thomas Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • COMPOSITIONS AND METHODS FOR MICRO-RNA EXPRESSION PROFILING OF CANCER STEM CELLS
    Publication number: 20120053224
    Abstract: The present invention relates compositions and methods for microRNA expression profiling of cancer stem cells. In particular, the invention relates to a method for identifying and/or diagnosing one or more cancer stem cells, the method comprising identifying from a plurality of nucleic acid molecules, each encoding a microRNA sequence, one or more nucleic acid molecules are differentially expressed in the cancer stem cells and in one or more control cells, wherein the one or more differentially expressed nucleic acid molecules together represent a nucleic acid expression signature that is indicative for the presence of cancer stem cells. The invention further relates to a corresponding diagnostic kit of molecular markers, namely the nucleic acid expression signature. Finally, the invention is directed to a method using such nucleic acid expression signatures for preventing the proliferation and/or self-renewal of such cancer stem cells as well as to a corresponding pharmaceutical composition.
    Type: Application
    Filed: December 4, 2009
    Publication date: March 1, 2012
    Applicant: Universitat Regensburg
    Inventors: Gunter Meister, Lasse Weinmann, Dagmar Beier, Christoph Beier
  • Anti-MicroRNA oligonucleotide molecules
    Patent number: 8114985
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: February 14, 2012
    Assignee: Rockefeller University
    Inventors: Thomas H. Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • Anti-MicroRNA Oligonucleotide Molecules
    Publication number: 20110165669
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Application
    Filed: March 11, 2011
    Publication date: July 7, 2011
    Applicant: ROCKEFELLER UNIVERSITY
    Inventors: Thomas Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • Anti-microRNA oligonucleotide molecules
    Patent number: 7943756
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: May 17, 2011
    Assignee: Rockefeller University
    Inventors: Thomas H. Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • Anti-MicroRNA Oligonucleotide Molecules
    Publication number: 20100286385
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Application
    Filed: June 4, 2010
    Publication date: November 11, 2010
    Applicant: ROCKEFELLER UNIVERSITY
    Inventors: Thomas Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • Anti-microRNA oligonucleotide molecules
    Patent number: 7772389
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: August 10, 2010
    Assignee: Rockefeller University
    Inventors: Thomas Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer
  • Anti-MicroRna Oligonucleotide Molecules
    Publication number: 20070287179
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Application
    Filed: February 11, 2005
    Publication date: December 13, 2007
    Inventors: Thomas Tuschl, Markus Landthaler, Gunter Meister, Pfeffer Sebastion
  • Anti-microRNA oligonucleotide molecules
    Publication number: 20050182005
    Abstract: The invention relates to isolated anti-microRNA molecules. In another embodiment, the invention relates to an isolated microRNA molecule. In yet another embodiment, the invention provides a method for inhibiting microRNP activity in a cell.
    Type: Application
    Filed: May 13, 2004
    Publication date: August 18, 2005
    Inventors: Thomas Tuschl, Markus Landthaler, Gunter Meister, Sebastien Pfeffer